旅游市场持续升温，2025年上半年，国内居民出游人次32.85亿，同比增长20.6%；国内居民出游花费 3.15万亿元，同比增长15.2%。 营收分化趋势凸显 但在市场复苏的浪潮中，上市旅企的半年"成绩单"却暗藏隐忧。 2025年上半年，Wind旅游及景区板块中，23家旅企营业收入合计175.5亿元，同比增长4.8%；实现归母 净利润11.67亿元，同比下降4.25%。这种营收上扬与利润下滑的鲜明反差，背后折射出旅企在成本控 制、产品结构、市场竞争等多方面面临的挑战。 从上半年财报数据来看，旅游企业在收入层面呈现出明显的分化态势。 其中，中青旅以48.66亿元的营收位居榜首，同比增幅达11.55%。目前，该公司主要投资运营管理乌 镇、古北水镇景区，同时，还布局旅行社以及酒店运营管理等业务。 然而，在上半年，两大核心景区面临双重挑战，受天气原因及周边市场竞争加剧影响，乌镇景区与古北 水镇景区游客接待数量均出现下滑，直接导致景区营收同步承压。其中，乌镇景区实现营业收入7.42亿 元，同比下降13.56%；古北水镇景区实现营业收入2.05亿元，同比下降25.29%。 值得庆幸的是，中青旅的旅行社业务以及策略性投资业 ...

（广东华兴银行） 注：业绩比较基准不是预期收益率，不代表产品的未来表现和实际收益，不构成对产品收益的承诺。 以上理财产品信息仅供参考，具体应以《产品说明书》等销售文件为准。本文不构成任何投资建议，投 资者据此操作，风险自担。 9月3日，据广东华兴银行披露，该行发行的映山红安心回报779号净值型理财认购期为2025年9月3日到 2025年9月8日，募集上限30亿元，1元人民币为1份，首次投资最低份额为5万份。产品类型为固定收益 类（投资类型）、非保本净值型、封闭式，风险评级为中等风险（R3），期限为420天，业绩基准区间 （年化）2.20%-3.50%。 ...

Group 1 - Qingdao Bank announced that it received approval from the National Financial Supervision Administration's Qingdao Regulatory Bureau for a change in shareholding, allowing Guoxin Chanin Holdings to increase its stake in the bank by up to 5% of the total share capital within six months [1] - As of the announcement date, Guoxin Chanin Holdings holds 655 million A-shares, accounting for 11.25% of Qingdao Bank's total shares, while its concerted action parties hold additional shares, bringing the total stake to 14.99% [1] - The planned increase in shareholding aims to recognize the long-term investment value of Qingdao Bank's stock and support the bank's long-term development [2] Group 2 - Guoxin Chanin Holdings plans to acquire between 23.3 million and 29.1 million additional shares through secondary market transactions, which will raise its total holding to between 19.00% and 19.99% [2]

Core Insights - The number of physical bank branches among China's six major state-owned banks has stabilized, with a slight decrease of approximately 42 branches as of mid-2025 compared to the beginning of the year [1][5] - The focus of branch adjustments is shifting towards key urban areas such as the Beijing-Tianjin-Hebei region and county-level operations, indicating a strategic realignment in service delivery [1][6] Summary by Bank - **Industrial and Commercial Bank of China (ICBC)**: As of June 2025, ICBC has a total of 16,354 branches, with 15,941 located domestically and 413 internationally [2] - **Agricultural Bank of China (ABC)**: ABC reported 22,914 domestic branches and 17 overseas institutions as of June 2025 [2] - **Bank of China (BOC)**: BOC has a total of 11,516 branches, with 10,977 in mainland China and 539 in Hong Kong, Macau, Taiwan, and other regions [2] - **China Construction Bank (CCB)**: CCB has 14,727 branches, including 14,178 domestic branches [3] - **Bank of Communications (BoCom)**: BoCom operates over 2,800 domestic branches and 24 overseas branches [3] - **Postal Savings Bank of China (PSBC)**: PSBC has 39,188 branches and 71,435 ATMs as of mid-2025 [3] Overall Trends - The total number of branches across the six major banks is approximately 108,000, showing a decrease of about 42 branches in the first half of 2025 compared to the end of 2024 [5] - The pace of branch closures has significantly slowed, with projections indicating a reduction of around 300 branches by the end of 2024 [5] - The current phase of branch adjustments is characterized by a balance between closing redundant branches and opening new ones in high-demand areas [6]

本轮推出的地块全部位于轨道交通站点周边市场需求突出、基础设施和公共服务配套较完善的区域。从 区域分布来看，核心区1宗（东城区）、中心城区2宗（朝阳区）、副中心及平原多点地区5宗（通州 区、顺义区、昌平区、大兴区、房山区各1宗）。具体如下： 东城区祈年大街路西危改工程项目，位于东城区天坛街道，二环内，邻近7号线桥湾站以及5号线和7号 线换乘站磁器口站，交通便捷。周边有北京医院、同仁医院、北京友谊医院，天坛公园，国瑞购物中 心、新世界百货、合景魔方购物中心等，生活配套成熟。 东城区祈年大街路西危改工程项目 9月3日，北京市规划和自然资源委员会官网发布了2025年第七轮拟供应商品住宅用地清单，共涉及8宗 地，土地面积约27公顷，建筑规模约63万平方米，上述用地拟于近期供应。 顺义区M15号线顺西路-府前街站土地一级开发项目SY00-0101-0318-1地块，位于顺义区仁和镇，六环 外，邻近地铁15号线石门站。周边有国泰宏城购物广场、隆华奥特莱斯购物广场、锦荟港等商业体，北 京京顺医院、望泉公园等，生活配套较完善。 永安里旧城区改建项目，位于朝阳区建外街道，地处东三环内、长安街南侧，紧邻地铁1号线和在建17 号线换 ...

【#国产多动症治疗药物上市# 立方制药已收获五连板】#国产聪明药正式上市# 9月2日，合肥立方制药 股份有限公司举办首发仪式，宣布其治疗注意缺陷多动障碍（ADHD，俗称"多动症"）的盐酸哌甲酯缓 释片正式上市销售。今年4月14日，立方制药公告称，盐酸哌甲酯缓释片（18mg）获得国家药监局批 准，用于治疗多动症。该药按照化学药品4类申报，属于国内首仿。受该消息的影响，立方制药在4月15 日至21日收获五连板。 在治疗方面，药物是成人多动症的重要治疗手段，其中长效哌甲酯缓释制剂是6岁以上多动症患者的一 线治疗药物，因此该药也被部分行业人士和患者称为"聪明药"。有数据显示，2023年全球多动症药物市 场规模为143.1亿美元，预计到2030年将达到186亿美元，年复合增长率为3.69%。 在立方制药之前，长效哌甲酯缓释制剂在中国境内仅有一家进口药品批准文号，由跨国药企强生持有， 最早于2005年8月在中国获批上市，商品名是专注达。 根据药智数据库统计，盐酸哌甲酯缓释片2023年国内样本医院的销售额约为3.5亿元，2024年前三季度 销售额进一步增长至约4.3亿元。（澎湃） 2024年7月,强生旗下的西安杨森曾对外发 ...

日期，雷诺集团宣布，梅赛德斯-奔驰前高管Katrin Adt出任达契亚品牌CEO，接替即将离职的Denis Le Vot。根据新的组织架构，Adt将向雷诺首席增长官Fabrice Cambolive汇报工作。（中国汽车报） ...

据统计，汽车整车概念股年内股价平均上涨8.47%。千里科技的股价涨幅最高，年内股价累计上涨 53.86%。从机构持股比例来看，二季度八成汽车整车概念股获机构加仓，其中13股机构持股比例环比 增加均超1个百分点，包含福田汽车、江淮汽车、中国重汽、宇通客车、上汽集团等个股。（新浪财 经） ...

Core Viewpoint - NIO has demonstrated significant operational improvement in Q2 2025, with substantial increases in vehicle deliveries, revenue, and gross margin, reflecting the effectiveness of its technological investments and organizational changes [1][2][4]. Financial Performance - In Q2 2025, NIO delivered 72,056 vehicles, a 71.2% increase quarter-over-quarter [1]. - Total revenue reached 19.01 billion yuan, with a quarter-over-quarter growth of 57.9% and a year-over-year increase of 9% [1]. - The overall gross margin improved to 10%, indicating a notable recovery in profitability [1][2]. Operational Efficiency - NIO has successfully implemented internal organizational changes and market policy adjustments, leading to a significant rebound in sales [2]. - The company has optimized costs through the mass production of its self-developed NX9031 chip, reducing costs by over 10,000 yuan per vehicle [2]. - The operational loss narrowed by over 30% quarter-over-quarter, showcasing improved operational quality [2]. Product Strategy - The launch of the L90 and the upcoming ES8 models are pivotal in driving NIO's operational turnaround, with the L90 achieving over 10,000 deliveries in its first month [3][5]. - Both models are positioned to meet the growing demand for large electric SUVs in the Chinese market, aligning with consumer preferences for spacious vehicles [3][5]. Market Confidence - NIO's stock prices have surged over 90% since the pre-sale of the L90, reflecting increased market confidence and trading activity [4]. - The dual positive signals from both the terminal market and capital market are providing strong support for the company's operational recovery [4]. Technological Advancements - NIO is experiencing a "technology harvest year" in 2025, with the launch of its 5nm driving chip and the SkyOS operating system, enhancing product competitiveness [6]. - The company has established a robust charging and battery swap network, with over 8,200 charging stations, facilitating the widespread adoption of its electric vehicles [6]. Organizational Optimization - NIO has restructured its operations into 12 core business units, improving efficiency and decision-making processes [7]. - The company reported a 40% increase in sales despite a 40% reduction in frontline sales personnel, indicating enhanced operational efficiency [7]. - August deliveries reached 31,305 vehicles, a nearly 50% increase month-over-month, further validating market confidence [7].

会上管理层介绍，上半年，公司新医疗战略稳步推进，截至2025年7月底，公司诊所会员店超2,400家， 计划三年内实现万家诊所联盟。公司旗下九医诊所公司主要以供应链业务为基础，聚焦全国诊所"产品 推广+会员联盟"，最终目标走向"医疗服务+供应链"融合的业务模式。 其中，在品种满足率方面，公司在已有供应链品种的基础上，不断引入诊所专销品种，完善诊所品种结 构，并与太极、华润三九、长风药业、吉林敖东、津药药业等多个上游厂家达成合作，上半年新品引入 超260个。 在数字化赋能方面，公司自主研发并上线九医SaaS诊所管家系统，为诊所客户提供数智化运营增值服 务，可实现3秒建档、10秒出方、医保结算、营收分析以及药品追溯码、5秒入库、效期预警等，目前 1,525家诊所会员店已上线使用该系统； 9月3日，九州通举办2025半年度业绩说明会。会上有投资者询问公司在AI技术应用方面的进展。对 此，管理层回应，公司积极拥抱 AI 人工智能技术，通过自主研发以及与阿里云、腾讯云等头部企业合 作等方式，开发针对不同应用场景的 AI 智能体，加速业务及管理的数智化转型。 目前，公司以 AI 技术、大模型为基础，结合自身业务及管理体系， ...